Imaging PD-L1 in the brain—Journey from the lab to the clinic
89Zr-DFO-Atezolizumab can visualize distinct PD-L1 expression levels with high specificity in preclinical mouse models and in patients with GBM, whilst complementing ex vivo analysis.
Authors
- Gabriela Krämer-Marek (ORCID: https://orcid.org/0000-0002-8053-3880)
- Ewa Chmielik (ORCID: https://orcid.org/0000-0001-8316-0541)
- Magdalena Rodak (ORCID: https://orcid.org/0000-0002-6829-8240)
- Gitanjali Sharma (ORCID: https://orcid.org/0000-0002-7291-9169)
- Andrea d’Amico (ORCID: https://orcid.org/0000-0003-4632-2139)
- Paweł Bzowski (ORCID: https://orcid.org/0000-0002-0689-1006)
- R. Tarnawski (ORCID: https://orcid.org/0000-0001-6802-5093)
- Marcin Niedbała (ORCID: https://orcid.org/0000-0002-6617-0155)
- Chiara Da Pieve (ORCID: https://orcid.org/0000-0002-9038-9659)
- Elżbieta Nowicka (ORCID: https://orcid.org/0000-0002-7993-8215)
- Wojciech Kaspera (ORCID: https://orcid.org/0000-0002-7139-3409)
- Barbara Bobek‐Billewicz (ORCID: https://orcid.org/0000-0003-3262-9738)
- Izabela Gorczewska (ORCID: https://orcid.org/0000-0003-1387-5503)
- Dawoud Dar (ORCID: https://orcid.org/0000-0002-8456-9506)
Institutions
- Medical University of Silesia (PL)
- National Institute of Oncology (HU)
- The Maria Sklodowska-Curie National Research Institute of Oncology (PL)
Publication Details
- Journal
- Neuro-Oncology
- Published
- 2024-10-28
- DOI
- https://doi.org/10.1093/neuonc/noae190
- Citations
- 9
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 3.94
Funders
- Agencja Badań Medycznych